sively.1 Procainamide plasma levels also have been the subject of much clinical research. It has been established that a concentration of 4-10 ug/ml encompasses the usual range of therapeutic plasma levels although lower concentrations may be associated with cessation of clinical arrhythmias.' 2 Concentrations higher than 10 ug/ml most often are associated with cardiac toxicity. ' The effects of procainamide on the electrophysiologic properties of isolated cardiac tissues have been documented. Hoffman, in studies on canine Purkinje fibers, 3 and Szekeres and Papp, in studies on rabbit atrium,4 have determined that procainamide decreases the automaticity of isolated cardiac tissues and slows conduction velocity. The latter change appears to accompany a loss in action potential amplitude and decrease in maximal slope of phase 0 of the action potential. However, for these changes to develop in isolated Purkinje fibers, concentrations of procainamide in Tyrode solution of at least 10-30 ,ug/ml were required. 4 The current study was undertaken to see if we could correlate findings for the three areas mentioned: clinical electrocardiographic effects of procainamide, therapeutic and toxic plasma concentrations, and electrophysiologic effects of procainamide on cells of the cardiac conducting system. To permit these correlations, we used a method developed in this laboratory for perfusion of isolated cardiac tissues with arterial blood from a donor animal.5
Methods
Nine experiments were conducted utilizing 18 mongrel dogs weighing 20-30 kg. For each experiment, one dog was anesthetized with sodium pentobarbital, 30 mg/kg. The heart was rapidly removed and the Purkinje fiber bundles were excised from right or left ventricle and pinned to the wax bottom of a Lucite perfusion chamber with a volu-me of 4.5 ml. They were then perfused with a modified Tyrode solution containing (in mM/liter) NaCl, 137; NaHCO3, 12; dextrose, 5.5; KCI, 4; NaH2PO4, 1 in duration and twice threshold was introduced at various levels of membrane potential during phases 3 and 4. Maximal slope of phase 0 of premature action potentials (R2) elicited at various times during the repolarization phase of the basic action potential (R1) was plotted as a function of the membrane voltage at which the R2 arose. The effective refractory period was studied by impaling one intracellular microelectrode in a Purkinje fiber approximately 3 mm from the stimulus site and the second microelectrode in a Purkinje fiber 4-10 mm from the proximal site and distal to the area of maximal action potential duration or gate.8 The earliest premature response (R.H) elicited at the proximal microelectrode site which propagated across the area of maximal action potential duration to the distal microelectrode site was considered to define the end of the effective refractory period.
To initiate blood perfusion the second (donor) dog was anesthetized with sodium pentobarbital and heparinized with 3 mg/kg sodium heparin. A femoral artery and vein were cannulated and arterial blood pumped into the tissue chamber in place of Tyrode solution. Effluent from the chamber was pumped through an air trap and infused into the femoral vein. Previous studies have shown the stability of this method and the viability of both the intact animal and the isolated tissues during blood perfusion.5 The differences between control values in Tyrode solution and blood have also been reported previously.5 Plasma electrolytes (Na, K, Cl, CO, Ca, and P) measured periodically during these studies (flame photometer or autoanalyzer) showed little variation. Figure 2C , recorded at the 90-min mark, demonstrates the steady state that was attained for action potential amplitude, maximal slope of phase 0, and voltage-time course of repolarization. After 90 min, a constant infusion of procainamide was commenced. The attainment of toxic concentrations accentuated the previously mentioned alterations in the action potential. This is seen Circulation, Volume XLVI, September 1972 in figure 2D , which was recorded 55 min after onset of the procainamide infusion.
Changes in the amplitude of action potentials recorded from 14 fibers during seven experiments are displayed graphically in figure 3 . The upper ordinate is action potential amplitude in mv; the lower, plasma procainamide concentration. Mean action potential amplitude and range were unchanged for approximately 20 min following the initial procainamide injection despite the high plasma concentrations achieved during this period. Twenty to 30 min after the injection, amplitude decreased and then remained stable within the new range for as long as the [5] [6] [7] [8] [9] [10] gg/ml plasma concentration was maintained.
As additional procainamide was infused, producing an increasing elevation in plasma concentration, there was a further decrease in action potential amplitude. The same type of relationship to procainamide concentration was found for values of maximal slope of phase 0. On the other hand, the 10-20 ,ug/ml range of procainamide concentration had no demonstrable effect on resting membrane potential.
Action Potential Repolarization
The changes in repolarization induced by procainamide are depicted in two representative experiments (fig. 4) . The purpose of these experiments is to show the variability of procainamide effect that may occur at different plasma potassium concentrations (K + O).
The action potentials in figure 4A , when plasma concentration was 7-8 ,g/ml and donor K + o 0 4 mEq/liter show there was no change in action potential duration measured to full repolarization but a decreased action potential duration measured to 50 and 75% repolarization. In the same experiment, when procainamide concentration was 14-15 ,ug/ml action potential duration at 50% repolarization was even shorter, while at 75% and 100% repolarization action potential duration had prolonged. figure 5 . The controls are shown in A. In figure  5B , 25 min after the initial injection of procainamide, action potential duration was prolonged from 230 to 270 msec, whereas effective refractory period increased from 200 to only 210 msec. This ratio between action potential duration and effective refractory period was maintained for the next 70 min as shown in figure 5C . refractoriness from beat to beat or an intermittent change in membrane responsiveness. In figure 5D , toxic concentrations of procainamide were attained. Action potential duration was now 325 msec and effective refractory period, 250 msec. In this instance, conduction of each R, to the distal site occurred but was slower than that in figure 5A and B. In every instance where effective refractory period was studied this variable changed in the same direction as action potential duration although tending to lag behind in magnitude of change. In three additional experiments where membrane responsiveness was evaluated no change occurred during maintenance of therapeutic procainamide plasma concentrations, but the curve was depressed at toxic levels.
Conduction Time and QRS Duration
Conduction time in isolated Purkinje fiber bundles and QRS duration of the donor electrocardiogram were studied in seven experiments, one of which is depicted in figure  6 . No change in overall heart rate occurred following procainamide injection. However, within 40 min QRS duration had prolonged from a control of 35 to 45 msec. Nearly simultaneous with the QRS alteration there was a prolongation in conduction time between the two recording sites in the isolated Purkinje fiber bundle, from a control value of 2.3 msec to 3.6 msec. In each experiment, procainamide brought about a change in QRS duration that correlated well in timing with the change in Purkinje fiber conduction.
Automaticity
The slope of phase 4 was recorded in seven experiments in which the Purkinje fibers were driven by an external stimulus. In every instance this variable decreased within 5-10 min after the initial injection of procainamide, suggesting that automaticity would have been decreased. One of the two additional experiments, in which Purkinje fibers were permitted to beat spontaneously during blood perfusion, is depicted in figure 7 . Within 4 min after injection of procainamide, spontaneous rate had decreased from a control of 60/min 7C ) rate had fallen to 40/min. These changes in rate were associated with a decrease in the slope of phase 4 depolarization ( fig. 7C ). Action potential amplitude, which initially decreased slightly, then increased markedly as is seen in figure 7C . The donor electrocardiogram (bottom) showed only a decrease in heart rate from 150 to 135 beats/min during this time.
Discussion
The two etiologies for ventricular arrhythmias most generally accepted are increased automaticity and altered conduction.10 Therapeutic concentrations of procainamide invariably decreased automaticity and depressed conduction during our experiments. Changes in conduction in isolated tissue and in electrocardiographic QRS duration occurred over a 20-40-min period. Automaticity, on the other hand, decreased within 5-10 min of drug administration. Although plasma levels were higher at the 5-10-min mark than they were at 20-40 min ( fig. 1) , it is probable that tissue concentrations of procainamide had not yet achieved as high a level at the earlier time as they did later on when conduction was being affected. The suggestion, then, is that a lower tissue concentration of procainamide is required to depress automaticity than to depress conduction. One may speculate that cardiac arrhythmias which respond to procainamide rapidly after intravenous administration might be due to aberrations in automaticity; those that respond more slowly might result from abnormal conduction.
The relationship between plasma concentration of drug and time is further demonstrated by comparing the electrophysiologic responses that occurred within 5 min after an initial injection and following subsequent elevation of plasma levels to the toxic range utilizing a procainamide infusion. Drug concentration per se is no different at the 5-and the 140-min mark, 20 ,ug/ml in both instances. Yet at 5 min Obviously, the only difference in the parameters measured here was that adequate time for equilibration of tissue and plasma concentrations had not occurred at the 5-min mark and did occur during the subsequent procainamide infusion until toxicity was seen. One view concerning the etiology of reentrant arrhythmias is that they result from unidirectional block in a depressed portion of the distal conducting system and retrograde conduction of impulses through this segment." By prolonging conduction time, as shown in figure 6 , propagation through such segments might be abolished by procainamide, and the arrhythmia stopped. Procainamide-induced alterations in conduction in these experiments invariably followed a decrease in action potential amplitude and maximal slope of phase 0. Two events might explain the drug-induced loss of action potential amplitude. One tendency toward prolongation of action potential duration measured at 50, 75, and 100% repolarization. In the higher potassium range, the action potential duration at 50 and 75% decreased, while at 100% repolarization it either remained unchanged or decreased slightly with therapeutic concentrations of procainamide, and prolonged when toxic concentrations were attained. The mechanisms behind these changes are currently being investigated.
The same direction of change noted for action potential duration was seen in evaluating effective refractory period. However, the latter did not necessarily keep pace with the former so that especially at higher drug concentrations the change in action potential duration was greater than that in effective refractory period. The slope of repolarization that was seen in any instance apparently depended on a combination of procainamide concentration and plasma potassium concentration. In the lower potassium range, due to increases in action potential duration and effective refractory period, refractoriness was prolonged and a premature beat that was conducted under control circumstances could no longer be conducted. At higher potassium concentrations lesser alterations in refractoriness and action potential duration were seen. To what extent premature beats occurring at the same membrane voltage might fail to be conducted is uncertain as membrane responsiveness was not significantly changed within the therapeutic concentration range. These observations concerning effective refractory period and membrane responsiveness suggest that altered response to premature impulses following procainamide may not be as consistent a mechanism for abolition of arrhythmias as are changes in conduction and automaticity.
At toxic plasma procainamide concentrations the decreases in action potential amplitude, maximal slope of phase 0, and conduction time were more marked than in the therapeutic range. Of greater interest here is the fact that action potential duration to 100% repolarization was prolonged in all experiments by toxic plasma concentrations of procainamide due to an altered slope of phase 3. This change was accompanied by a marked decrease in membrane responsiveness which could lead to decremental conduction in Purkinje fibers that previously conducted normally. This supports the theory that druginduced decremental conduction may be a major mechanism for production of arrhythmias due to procainamide toxicity.13
